Sponsors

Lead Sponsor

University of California, San Francisco

Collaborators

Akili Interactive Labs, Inc.

PRIMARY OBJECTIVES: I. Determine the recruitment and retention rates for both arms of this study. II. Determine the effect size for changes in cognitive function (i.e., Test of Variables of Attention (TOVA) \[i.e. attention\], Adaptive Cognitive Evaluation (ACE) \[i.e. working memory\]) in the intervention group compared to the control group following the 4-week study. III. Evaluate adherence rates for and satisfaction with the interventions. IV. Evaluate for treatment-related adverse events (e.g., nausea, motion sickness). SECONDARY OBJECTIVE: I. To determine effect sizes for depression, fatigue, and sleep disturbance, by comparing changes in the intervention group to changes in the control group, following the 4-week study. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients play Endeavor over 25 minutes daily 5 days a week for 4 weeks. ARM II: Patients play Words! over 25 minutes daily 5 days a week for 4 weeks.

Related studies

RECRUITINGNA

A Mindfulness-Based Stress Reduction Program for Improving Mental Health Outcomes for Underserved Cancer Patients in Minnesota

NCT07291011 · Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

RECRUITINGPhase 2

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

NCT06311214 · Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm

RECRUITINGPhase 1

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

NCT05687110 · Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm

RECRUITINGPhase 2

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

NCT04771520 · Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, and more

RECRUITINGNA

Increasing Knowledge and Interest in Cancer Clinical Trials

NCT06501040 · Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm

View all related studies →

Study of Attention and Memory Treatments for Cancer Survivors

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

A Mindfulness-Based Stress Reduction Program for Improving Mental Health Outcomes for Underserved Cancer Patients in Minnesota

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

Increasing Knowledge and Interest in Cancer Clinical Trials

Trial snapshot

Condition

Locations shown

For caregivers